Advenica

Advenica is a Swedish cybersecurity company focused on encryption and network segmentation for organizations with high security requirements. The company is based in Malmö, Sweden, with additional offices in Helsinki and Vienna, and most of its products are designed, developed, and manufactured in Sweden.

— Advenica
%
Encryption products45% Hardware and software solutions that protect sensitive data and communications.
Network segmentation25% Products that separate networks and control data flows between security domains.
Custom development / Design House20% Tailored cybersecurity product development for national-security use cases.
Support, maintenance and services10% Implementation, maintenance and related services for deployed security systems.

Advenica sells primarily to organizations that handle sensitive information and require approved security solutions...

  • Defenceprimary

    Buys approved encryption and segmentation products for mission-critical and classified environments.

  • Authoritiesprimary

    Buys security solutions for government communications, data protection and secure operations.

  • Infrastructureprimary

    Buys products to protect critical infrastructure networks and operational technology.

  • Industrysecondary

    Buys cybersecurity products to isolate systems and protect sensitive industrial data.

Advenica is headquartered in Malmö, Sweden, where most of its products are developed and manufactured...

  • •Headquartered in Malmö, Sweden, with most product development and manufacturing there
  • •Additional offices in Helsinki and Vienna support regional sales and delivery
  • •Revenue is concentrated in Sweden and Finland based on reported market split
  • •Smaller revenue comes from other countries as international reach expands
  • •Geography matters because public-sector demand is tied to local approvals and trust

Advenica’s strategy centers on developing its own cybersecurity products and combining them with tailored solutions for...

01
Grow the proprietary product portfoliomedium-term

Own products improve differentiation, control over roadmap and long-term customer relationships.

02
Deepen penetration in defence and public-sector marketsmedium-term

These customers value approvals, trust and long product lifecycles, which fit Advenica's model.

03
Broaden international presencelong-term

A wider geographic footprint reduces dependence on a small home market and expands addressable demand.

Advenica depends on a relatively small set of high-security customers, so order timing and project concentration can...

high

Customer concentration

A limited number of authorities and defence buyers can drive a large share of revenue.

Scope
Defence and Swedish public-sector customers
Materiality
high
high

Product approval and certification risk

Security products must meet EU and national approvals before they can be sold in sensitive environments.

Scope
Encryption and network segmentation products
Materiality
high
medium

Technology obsolescence

Cyber threats and customer requirements change quickly, so products can lose relevance without continued development.

Scope
All cybersecurity offerings
Materiality
high
medium

Project and order timing volatility

Large public-sector contracts can create uneven revenue recognition and backlog conversion.

Scope
Large customer contracts and development orders
Materiality
medium
Revenue recognition timing
Point-in-time versus over-time recognition can shift quarterly results
Capitalized development costs
Affects operating expenses, asset balances and future amortization
Inventory and project costs
Impacts gross margin timing and working capital
Impairment of intangible assets
Could lead to write-downs if products underperform

Avidbank Holdings, Inc.

AVBH · State Commercial Banks

Avidia Bancorp, Inc.

AVBC · Savings Institutions, Not Federally Chartered

Adicet Bio, Inc.

ACET · Pharmaceutical Preparations

ABEONA THERAPEUTICS INC.

ABEO · Pharmaceutical Preparations

ABVC BIOPHARMA, INC.

ABVC · Pharmaceutical Preparations

ADC Therapeutics SA

ADCT · Pharmaceutical Preparations

: 11/08/2026